title: Disposition of the neuroleptics perphenazine, zuclopenthixol, and haloperidol cosegregates with polymorphic debrisoquine hydroxylation.
authors.affiliation: Department of Clinical Pharmacology, Karolinska Institute, Huddinge Hospital, Sweden.
authors.forename: L
authors.initials: L
authors.lastname: Bertilsson
authors.forename: M L
authors.initials: ML
authors.lastname: Dahl
authors.forename: B
authors.initials: B
authors.lastname: Ekqvist
authors.forename: A
authors.initials: A
authors.lastname: Llerena
mesh_terms: D014150:Antipsychotic Agents / Q000378:metabolism*; D003006:Clopenthixol / Q000378:metabolism; D003647:Debrisoquin / Q000378:metabolism*; D006220:Haloperidol / Q000378:metabolism; D006801:Humans; D006900:Hydroxylation; D010546:Perphenazine / Q000378:metabolism; D011110:Polymorphism, Genetic
chemical_list: D014150:Antipsychotic Agents; D003006:Clopenthixol; D010546:Perphenazine; D006220:Haloperidol; D003647:Debrisoquin